Overactive Bladder :: Botox botulinum toxin for overactive bladder disease
Pioneering medical research is going on at the University of Leicester into the use of Botulinum toxin — commonly thought of as a beauty treatment — for bladder problems.
Pioneering medical research is going on at the University of Leicester into the use of Botulinum toxin — commonly thought of as a beauty treatment — for bladder problems.
Two researchers from the University Hospital and the Center for Applied Medical Research (CIMA) from the University of Navarra have published an article in Nature Cancer Reviews.
Genetic analysis has enabled the personalising of the pharmaceutical treatment of patients with cancer, enhancing thereby therapeutic efficacy and minimising possible toxicity.
Scientists at the University of Cambridge have discovered why some individuals may be predisposed to drug addiction and believe it may lead to better treatments for this brain disorder.
Scientists at the University of Cambridge have discovered why some individuals may be predisposed to drug addiction and believe it may lead to better treatments for this brain disorder.
There is no clear benefit from a hormone commonly prescribed to enhance the effectiveness of infertility treatments, according to a new review of studies.
A new Australian Centre for Gynaecological Cancers is to be set up by the Commonwealth Government to help combat gynaecological cancer.
Small populations of Melanesians — among the most genetically diverse people on the planet — have significant differences in their mitochondrial DNA that can be linked to where they live, the size of their home island and the language they speak.
The tiny Drosophila fruit fly may pave the way to new methods for studying and finding treatments for heart disease, the leading cause of death in industrialized countries, according to a collaborative study by the Burnham Institute for Medical Research, UC San Diego (UCSD) and the University of Michigan.
Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.